As Insmed Incorporated (INSM) Stock Price Rose, Holder Foresite Capital Management Ii LLC Lifted Stake

June 13, 2018 - By Adrian Mccoy

Insmed Incorporated (NASDAQ:INSM) LogoInvestors sentiment increased to 1.46 in 2018 Q1. Its up 0.46, from 1 in 2017Q4. It is positive, as 18 investors sold INSM shares while 30 reduced holdings. 23 funds opened positions while 47 raised stakes. 77.55 million shares or 5.92% more from 73.21 million shares in 2017Q4 were reported. Hbk Invs Limited Partnership accumulated 98,252 shares. State Common Retirement Fund, New York-based fund reported 82,100 shares. Rock Springs Cap Mgmt Limited Partnership holds 0.79% of its portfolio in Insmed Incorporated (NASDAQ:INSM) for 825,000 shares. Sabby Mngmt invested 0.04% of its portfolio in Insmed Incorporated (NASDAQ:INSM). Savings Bank Of America De invested 0% of its portfolio in Insmed Incorporated (NASDAQ:INSM). Earnest Prns Ltd Liability Com holds 1,130 shares or 0% of its portfolio. 12.58 million are held by Price T Rowe Assocs Inc Md. Secor Capital Advisors Limited Partnership reported 0.03% in Insmed Incorporated (NASDAQ:INSM). 4,034 were reported by Tower Cap Limited Company (Trc). Jpmorgan Chase Communication reported 0% stake. Synovus Fincl Corporation reported 50 shares. Quantbot Ltd Partnership stated it has 0.01% of its portfolio in Insmed Incorporated (NASDAQ:INSM). Qs Ltd holds 71,511 shares or 0.02% of its portfolio. Legal & General Public Ltd holds 29,657 shares or 0% of its portfolio. Emerald Advisers Incorporated Pa reported 726,946 shares.

Since May 29, 2018, it had 0 insider buys, and 1 insider sale for $1.05 million activity.

Jim Tanenbaum increased its stake in Insmed Incorporated (INSM) by 86.57% based on its latest 2018Q1 regulatory filing with the SEC. Foresite Capital Management Ii Llc bought 448,991 shares as the company’s stock rose 4.66% while stock markets declined. The hedge fund run by Jim Tanenbaum held 967,636 shares of the health care company at the end of 2018Q1, valued at $21.79M, up from 518,645 at the end of the previous reported quarter. Foresite Capital Management Ii Llc who had been investing in Insmed Incorporated for a number of months, seems to be bullish on the $2.22 billion market cap company. The stock increased 0.42% or $0.12 during the last trading session, reaching $28.92. About 97,159 shares traded. Insmed Incorporated (NASDAQ:INSM) has risen 61.09% since June 13, 2017 and is uptrending. It has outperformed by 48.52% the S&P500.

More notable recent Insmed Incorporated (NASDAQ:INSM) news were published by: Streetinsider.com which released: “Insmed (INSM) Announces FDA Acceptance for Filing of NDA for ALIS in NTM Lung Disease Caused by MAC” on May 16, 2018, also Globenewswire.com with their article: “Recent Analysis Shows Northwest Natural Gas, Brooks Automation, Insmed, Host Hotels & Resorts, Prospect Capital …” published on May 30, 2018, Seekingalpha.com published: “Insmed: PDUFA Date Will Be A Game Changer” on June 04, 2018. More interesting news about Insmed Incorporated (NASDAQ:INSM) were released by: Nasdaq.com and their article: “Insmed Announces Presentations at the American Thoracic Society 2018 International Conference” published on May 22, 2018 as well as Globenewswire.com‘s news article titled: “Insmed Appoints Leo Lee to its Board of Directors” with publication date: May 17, 2018.

Insmed Incorporated (NASDAQ:INSM) Ratings Coverage

Among 6 analysts covering Insmed (NASDAQ:INSM), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Insmed had 7 analyst reports since January 4, 2018 according to SRatingsIntel. As per Thursday, January 4, the company rating was upgraded by Stifel Nicolaus. H.C. Wainwright maintained Insmed Incorporated (NASDAQ:INSM) on Thursday, January 4 with “Buy” rating. The stock of Insmed Incorporated (NASDAQ:INSM) has “Buy” rating given on Thursday, January 4 by Robert W. Baird. The stock has “Buy” rating by Leerink Swann on Wednesday, March 14. Credit Suisse upgraded the stock to “Outperform” rating in Monday, April 23 report. The stock of Insmed Incorporated (NASDAQ:INSM) earned “Buy” rating by H.C. Wainwright on Thursday, June 7.

Insmed Incorporated (NASDAQ:INSM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.